Pediatric Multiple Sclerosis in Tunisia: A Retrospective Study over 11 Years. (7th November 2017)

• Record Type: Journal Article
• Authors: Ben Achour, Nedia; Rebai, Ibtihel; Raddadi, Sarra; Benrhouma, Hanene; Klaa, Hedia; Rouissi, Aida; Kraoua, Ichraf; Ben Youssef Turki, Ilhem
• Other Names: Prosperini Luca Academic Editor.
• Is Part Of: BioMed research international. Volume 2017(2017)
• Publication Date: 2017-11-07
• Subjects: Medicine -- Periodicals; Biology -- Periodicals; Biotechnology -- Periodicals; Life sciences -- Periodicals; 610.5
• DOI: 10.1155/2017/4354826
• Languages: English
• ISSNs: 2314-6133

Abstract

Abstract : Introduction . Pediatric multiple sclerosis (pMS) is a rare demyelinating disorder with an onset before the age of 18 years. In this study, we aimed to investigate the characteristics of pMS in Tunisian children. Patients and Methods . We conducted a retrospective study over 11 years (2005–2016) including all patients diagnosed with pMS according to the International Pediatric Multiple Sclerosis Study Group (IPMSSG) criteria of 2012 and followed up in a tertiary care research center. Epidemiological, clinical, neuroimaging, laboratory, and therapeutic data were collected and analyzed. Results . There were 21 patients. The male-female ratio was 1 : 3. Mean age at onset was 11 years (range: 3–17 years). Three patients had type 1 diabetes. Polyfocal presentation was preponderant (81%) with motor dysfunction in 57% of patients. Paroxysmal dystonia was noticed in 24%. All patients were diagnosed with relapsing-remitting form. Interferon beta was prescribed in 80% with a reduction of annual relapse rate. Conclusion . The annual incidence of pMS in Tunisian children aged below 18 years could be estimated as 0.05 per 100, 000. Singular features in our cohort were the frequent association with type 1 diabetes and the increased occurrence of dystonia. Greater awareness of pMS may be helpful to improve management strategies of children and their families.